Journal Basic Info
- Impact Factor: 1.995**
- H-Index: 8
- ISSN: 2474-1647
- DOI: 10.25107/2474-1647
Major Scope
- Transplant Surgery
- Breast Surgery
- Ophthalmic Surgery
- Pediatric Surgery
- Otolaryngology - Head and Neck Surgery
- Oral and Maxillofacial Surgery
- Colon and Rectal Surgery
- Surgical Oncology
Abstract
Citation: Clin Surg. 2017;2(1):1413.case Report | Open Access
Guillain-Barre Syndrome Following PCV Vaccine
Nidhi Ravishankar
Department of Internal Medicine, Windsor University School of Medicine, USA
*Correspondance to: Nidhi Ravishankar
PDF Full Text DOI: 10.25107/2474-1647.1413
Abstract
Guillain-Barre syndrome (GBS) is a rapid-onset muscle weakness caused by the immune system attacking the peripheral nervous system. Although the causes still remain elusive, many studies in the past have linked GBS to vaccinations, such as influenza, but pneumococcal vaccine remains to be studied. This case report highlights a woman who developed bilateral lower extremity weakness from Guillain-Barre a month after administration of the PCV vaccine and subsequent respiratory failure. Possible etiology could be linked to the T-dependent stimulation response of GBS to the G1-specific B cells found in the peripheral blood. Full recovery is often rare in the syndrome, but rapid administration of IV Ig and extensive therapy has proved to show a good long-term outcome.
Keywords
Guillain-Barre syndrome; PCV vaccine; Peripheral nervous system
Cite the article
Ravishankar N. Guillain-Barre Syndrome Following PCV Vaccine. Clin Surg. 2017; 2: 1413.
